Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry
Mm. Brooks et al., Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry, CIRCULATION, 101(23), 2000, pp. 2682-2689
Citations number
19
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-The impact of percutaneous transluminal coronary angioplasty (PT
CA) and coronary artery bypass grafting (CABG) on long-term mortality rates
in the presence of various demographic, clinical, and angiographic factors
is uncertain in the population of patients suitable for both procedures.
Methods and Results-In the Bypass Angioplasty Revascularization Investigati
on (BARI) randomized trial and registry, 3610 patients who were eligible to
receive PTCA and CABG were revascularized between 1989 and 1993. Multivari
ate Cox models were used to identify factors associated with 5-year mortali
ty and cardiac mortality, with particular attention to factors that interac
t with treatment. Diabetic patients receiving insulin had higher mortality
and cardiac mortality rates with PTCA compared with CABG (relative risk [RR
] 1.78 and 2.63, respectively, P<0.001), and patients with ST elevation had
higher cardiac mortality rates with CABG than with PTCA (RR 4.08, P<0.001)
. Factors most strongly associated with high overall mortality rates were i
nsulin-treated diabetes, congestive heart failure, kidney failure, and olde
r age. Black race was also associated with higher mortality rates (RR 1.49,
P=0.19).
Conclusions-A set of variables was identified that could be used to help se
lect a revascularization procedure and to evaluate risk of long-term mortal
ity in the population of patients considering revascularization.